| Literature DB >> 34283264 |
Evânio Vilela Silva1, Luciana Yamamoto Almeida1, Karen Cristine Bortoletto2, Isabela Barbosa Quero2, Fernanda Carolina Jacomini2, Bruno Augusto Benevenuto de Andrade3, Heitor Albergoni Silveira1, Andressa Duarte4, Flávio Calil Petean5, Eduardo Melani Rocha5, Alfredo Ribeiro-Silva4, Román Carlos6, Jorge Esquiche León7.
Abstract
Focal lymphocytic sialadenitis (FLS), an important diagnostic criterion for Sjögren's syndrome (SS) diagnosis, can also be observed when assessing minor salivary gland (mSG) biopsies from healthy asymptomatic individuals (non-SS patients). Fifty cases of primary SS (pSS group) and 31 cases of oral reactive lesions (non-SS non-sicca group) containing also typical FLS features, were assessed by morphological and immunohistochemical (CD10, CD23 and Bcl-6) analysis, aiming at the detection of GCs. All pSS cases showed FLS with focus score (FS) ≥ 1. In the non-SS non-sicca group, 12, 10 and 9 cases showed FLS with FS ≥ 1, FLS with FS < 1 and FLS associated with chronic sclerosing sialadenitis with FS < 1, respectively. The morphological analysis revealed similar frequency of GCs in pSS (20%) and non-SS non-sicca group (19%). The area (p = 0.052) and largest diameter (p = 0.245) of GCs were higher in pSS than non-SS non-sicca group. The FS and number of foci were significantly higher in pSS than non-SS non-sicca group with FS < 1. Immunohistochemistry confirmed all morphological findings (GCs showing CD23 and Bcl-6 positivity, with variable CD10 expression) and additionally in 3 and 1 cases of the pSS and non-SS non-sicca group, respectively. Moreover, another 6 and 2 cases of the pSS and non-SS non-sicca group with FS ≥ 1, respectively, showed positivity only for CD23. FLS can also be observed when assessing oral reactive lesions, which showed similar frequency of GCs with those found in pSS patients. Further studies, including functional analysis of lymphocytic populations and GCs in FLS, are encouraged.Entities:
Keywords: Ectopic germinal centers; Focal lymphocytic sialadenitis; Immunohistochemistry; Non-Sjögren’s non-sicca patient; Oral reactive lesions; Sjögren’s syndrome
Mesh:
Year: 2021 PMID: 34283264 DOI: 10.1007/s00296-021-04949-6
Source DB: PubMed Journal: Rheumatol Int ISSN: 0172-8172 Impact factor: 3.580